PATENT CLAIM ANALYSIS

Application Number: 16276331
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "247000"]

Abstract:
The invention relates to particular substituted heterocycle fused gamma-carbolines, their prodrugs, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT 2A  receptor, the serotonin transporter (SERT), pathways involving the dopamine D 1  and D 2  receptor signaling system, and/or the μ-opioid receptor.

Claim (Index 24):
The composition according to  claim 22 , wherein the pharmaceutically acceptable diluent or carrier comprises a polymeric matrix.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.37736
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15660615', '15629481', '13642652', '14627968', '16056143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8188447923432212
- 35 USC 102 Novelty (BERT): 0.5459760632989792
- Combined Prediction Score: 0.791557919438797
- Mean Citation Score: 316.946048
- Max Citation Score: 368.0655
- Similarity Product: 319.8245962933302

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test